Accéder au contenu
Merck

Toward bifunctional antibody catalysis.

Bioorganic & medicinal chemistry (2006-06-20)
Kazuya Kikuchi, Renate B Hannak, Mao-Jun Guo, Anthony J Kirby, Donald Hilvert
RÉSUMÉ

Antibodies that catalyze the deprotonation of unactivated benzisoxazoles to give the corresponding salicylonitriles were prepared using as antigen a 2-aminobenzimidazolium derivative coupled to a carrier protein via its benzene ring. The hapten was designed to induce an antibody binding site with both a base and an acid, in position to initiate proton transfer and stabilize developing negative charge at the phenoxide leaving group, respectively. Consistent with this design, the catalysts exhibit bell-shaped pH-rate profiles, while chemical modification identified several functional groups that could participate in bifunctional catalysis. One of the antibodies, 13G5, is particularly notable in catalyzing the elimination of 6-glutaramidebenzisoxazole with a > 10(5)-fold rate acceleration over background and an effective molarity of > 10(4) M for its catalytic base. These properties compare favorably to the efficiencies achieved by the best previously characterized antibodies with substantially more reactive substrates.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
2-Aminobenzimidazole, 97%